Zaltrap and Scan abnormal - a phase IV clinical study of FDA data

Summary:

We study 1,858 people who take Zaltrap (ziv-aflibercept) or have Scan abnormal. No report of Scan abnormal is found in people who take Zaltrap.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

What is Zaltrap?

Zaltrap has active ingredients of ziv-aflibercept. eHealthMe is studying from 1,432 Zaltrap users. Check the latest studies of Zaltrap.

What is Scan Abnormal?

Scan abnormal is found to be associated with 107 drugs and 100 conditions by eHealthMe. Check the latest studies of Scan abnormal.

On Jul, 22, 2026

No report is found.

Do you take Zaltrap and have Scan abnormal?

- Check whether Scan abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zaltrap:

Zaltrap (1,432 reports)

Scan abnormal treatments and more:

Scan abnormal (426 reports)

How severe was Scan abnormal and when was it recovered:

Scan abnormal in Zaltrap

Expand to all the drugs that have ingredients of ziv-aflibercept:

Scan abnormal and drugs with ingredients of ziv-aflibercept

Browse all side effects of Zaltrap:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Scan abnormal:

Scan abnormal

Browse all the conditions that are associated with Scan abnormal:

Scan abnormal

How the study uses the data?

The study uses data from the FDA. It is based on ziv-aflibercept (the active ingredients of Zaltrap) and Zaltrap (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.